March 9, 2018 / 1:47 PM / 5 months ago

BRIEF-Covance Forms Immunology & Immunotoxicology Unit Focused On Biologic Drug Development

March 9 (Reuters) - Laboratory Corporation Of America Holdings:

* COVANCE FORMS IMMUNOLOGY & IMMUNOTOXICOLOGY UNIT FOCUSED ON BIOLOGIC DRUG DEVELOPMENT

* LABCORP - COVANCE DRUG DEVELOPMENT BUSINESS HAS FORMED A GLOBAL IMMUNOLOGY AND IMMUNOTOXICOLOGY UNIT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below